However, other types of samples cannot be substituted for colorectal cancer tissues for K-ras mutation detection, considering that the detection frequency of K-ras mutations in tumor tissues is 4-fold that of plasma samples, with the difference between sample types being statistically significant for colorectal cancer patients. Here, KRAS is linked to colorectal cancer.